Skip to main content
. 2011 Jan;36(1):47–55. doi: 10.1503/jpn.090116

Table 1.

Summary of demographic, postmortem and medication variables in the control and psychiatric groups

Variable Control, n = 35 Schizophrenia, n = 35 Bipolar disorder, n = 34
Demographic
Age at death, mean (SD) yr 44.2 (7.6) 42.6 (8.5) 45.4 (10.7)
Sex, male:female 26:9 26:9 16:18
Postmortem characteristic
Postmortem interval, mean (SD) h 29.4 (12.9) 31.4 (15.5) 37.9 (18.6)
Brain pH, mean (SD) 6.6 (0.3) 6.5 (0.2) 6.4 (0.3)
Brain hemisphere, right:left 16:19 17:18 19:15
Clinical
Cause of death
 Cardiopulmonary 33 21 7
 Suicide 7 15
 Other 2 7 12
Age at onset, mean (SD) yr 21.3 (6.1) 25.3 (9.2)
Duration of disorder, mean (SD) yr 21.29 (10.15) 20.15 (9.462)
Antipsychotic dose, median (range) mg* 48000 (50–400000) 3000 (0–13000)
Alcohol history, none/mild:moderate or heavy past or present use 30:5 17:18 12:21 (1 missing)
Drug history, none/mild:moderate or heavy past or present use 35:0 18:15 (2 missing) 15:19

SD = standard deviation.

*

Antipsychotic dose is lifetime dose in chlorpromazine milligram equivalents.

p < 0.05, statistically significant differences between the psychiatric and control groups.